Trials / Completed
CompletedNCT03350503
AcrySof IQ Toric A-Code Post-Market Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 125 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to clinically confirm the rotational stability of a modified AcrySof IQ toric intraocular lens (IOL) in a Japanese population.
Detailed description
Patients will be examined pre-operatively to up to 3 years post-operatively. One eligible eye will be selected as a target eye for efficacy analysis. If both eyes are eligible, the eye in which the IOL is implanted first will be selected as the target eye.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AcrySof IQ Toric A-code IOL | Intended to provide visual acuity, including astigmatism correction, over the lifetime of the cataract patient |
| PROCEDURE | Cataract surgery | Removal of cataractous lens and implantation of IOL |
Timeline
- Start date
- 2018-01-30
- Primary completion
- 2019-05-23
- Completion
- 2021-12-17
- First posted
- 2017-11-22
- Last updated
- 2022-12-28
- Results posted
- 2020-05-12
Locations
4 sites across 1 country: Japan
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03350503. Inclusion in this directory is not an endorsement.